Antipsychotics for aggression in adults: A meta-analysis

作者: Gerrit I. van Schalkwyk , Chad Beyer , Jessica Johnson , Morgan Deal , Michael H. Bloch

DOI: 10.1016/J.PNPBP.2017.07.019

关键词:

摘要: Aggressive behavior complicates the presentation of many psychiatric illnesses, and is associated with significant morbidity. Antipsychotic medications are used to treat this symptom dimension across multiple diagnoses. In meta-analysis we sought identify effect size antipsychotic for treatment reactive-impulsive aggression in adults, differences underlying diagnosis specific agent. A search was conducted four databases, MEDLINE, PsychINFO, Embase Cochrane Library end date August 10, 2016. The terms included "aggression", "irritable mood", "anger", "hostility" "antipsychotic agents" or "dopamine antagonists". 505 results were found, which 47 reviewed detail 21 ultimately analysis. Antipsychotics broadly effective aggression, but sizes similar those non-pharmacologic interventions (standard mean difference=0.29, 95% confidence interval 0.22-0.36, z=8.5, p<0.001). There no evidence according choice agent (χ2=2.7, df=6, p=0.85), conclusive as importance (χ2=3.2, df=3, p=0.36). small dose identified (β=0.0002, CI 0.0001-0.0004, p=0.038). Although antipsychotics appear be their context side-effects should taken into account when making clinical decisions about use.

参考文章(54)
D. Paleacu, Y. Barak, I. Mirecky, D. Mazeh, Quetiapine treatment for behavioural and psychological symptoms of dementia in Alzheimer's disease patients: a 6-week, double-blind, placebo-controlled study. International Journal of Geriatric Psychiatry. ,vol. 23, pp. 393- 400 ,(2008) , 10.1002/GPS.1892
Victor Peralta, Manuel J. Cuesta, Psychometric properties of the Positive and Negative Syndrome Scale (PANSS) in schizophrenia Psychiatry Research. ,vol. 53, pp. 31- 40 ,(1994) , 10.1016/0165-1781(94)90093-0
Stephen Crystal, Mark Olfson, Cecilia Huang, Harold Pincus, Tobias Gerhard, Broadened Use Of Atypical Antipsychotics: Safety, Effectiveness, And Policy Challenges Health Affairs. ,vol. 28, ,(2009) , 10.1377/HLTHAFF.28.5.W770
P.E. Keck, P.J. Orsulak, A.J. Cutler, R. Sanchez, A. Torbeyns, R.N. Marcus, R.D. McQuade, W.H. Carson, Aripiprazole monotherapy in the treatment of acute bipolar I mania: a randomized, double-blind, placebo- and lithium-controlled study. Journal of Affective Disorders. ,vol. 112, pp. 36- 49 ,(2009) , 10.1016/J.JAD.2008.05.014
Henry Brodaty, David Ames, John Snowdon, Michael Woodward, Jeff Kirwan, Roger Clarnette, Emma Lee, Ben Lyons, Fred Grossman, A Randomized Placebo-Controlled Trial of Risperidone for the Treatment of Aggression, Agitation, and Psychosis of Dementia The Journal of Clinical Psychiatry. ,vol. 64, pp. 134- 143 ,(2003) , 10.4088/JCP.V64N0205
Randy J. Nelson, Brian C. Trainor, Neural mechanisms of aggression Nature Reviews Neuroscience. ,vol. 8, pp. 536- 546 ,(2007) , 10.1038/NRN2174
Ira R. Katz, Dilip V. Jeste, Jacobo E. Mintzer, Christopher Clyde, Judy Napolitano, Martin Brecher, , Comparison of risperidone and placebo for psychosis and behavioral disturbances associated with dementia: a randomized, double-blind trial. Risperidone Study Group. The Journal of Clinical Psychiatry. ,vol. 60, pp. 107- 115 ,(1999) , 10.4088/JCP.V60N0207
Pal Czobor, Jan Volavka, Richard C. Meibach, Effect of risperidone on hostility in schizophrenia. Journal of Clinical Psychopharmacology. ,vol. 15, pp. 243- 249 ,(1995) , 10.1097/00004714-199508000-00002